← FDA Drug Approvals (Drugs@FDA)

XIFAXAN

NDA · New Drug Application · Sponsor: SALIX PHARMS · Approved 2010-03-24

Drug application

FDA Application #

NDA022554

Application type

New Drug Application

Brand name

XIFAXAN

Generic name

Rifaximin

Active ingredients

RIFAXIMIN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SALIX PHARMS

First approval

2010-03-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown